The authors report on 84 patients with single melanoma brain metastasis surgically treated from 1997 to 2007. There were 46 males and 38 females; mean age was 41 years (range 24-58 years). All patients were surgically treated, and 52 of them received postoperative adjuvant therapy consisting of whole-brain radiation therapy (36), radiosurgery (9), or a combination of these two techniques (7). Brain recurrences were observed in 44 cases, of which 9 were local. Of the latter, seven were re-operated while the remaining two were treated by radiosurgery. At 1-year follow-up, the survival rate was 52% (32 patients) whereas only 12 patients (14%) were still alive after 2 years. None of the patients in which removal was subtotal survived for more t...
Despite review papers claim for radical treatment of oligometastatic patients, only few surgical ser...
With an incidence of 15/10(5) in the general population, brain metastases constitute a serious, debi...
BACKGROUND: Brain metastasis is a common endpoint in patients suffering from malignant melanoma. How...
Melanoma is the sixth most common form of cancer in the United States. Moreover, it is the third mos...
We report a series of 240 patients with single brain metastases operated on between 1976 and 1993, T...
Background. Historically, melanoma with brain metastases has a poor prognosis. In this retrospective...
Background: Brain metastases are observed in more than 40% of all patients with stage 4 melanoma. In...
Melanoma spreads to the CNS with an incidence of 4 to 20%. Metastases from cancer of the colorectal ...
Thirty-four breast cancer patients with single brain metastases were reviewed: 9 underwent surgical ...
AIM: Improved systemic treatment has improved the prognosis of metastatic melanoma (MM). However, br...
Background Brain metastases occur in 10%–40% of patients with cancer and are more common than primar...
The management of melanoma brain metastases (MBM) includes different therapeutic modalities, such as...
Brain metastases (BM) are among the most devastating and debilitating complications of melanoma. Thi...
Cerebral metastases are a common cause of death in patients with melanoma. Systemic drug treatment o...
ABSTRACT CONTEXT: Malignant melanoma is the third most common cause of cerebral metastases after br...
Despite review papers claim for radical treatment of oligometastatic patients, only few surgical ser...
With an incidence of 15/10(5) in the general population, brain metastases constitute a serious, debi...
BACKGROUND: Brain metastasis is a common endpoint in patients suffering from malignant melanoma. How...
Melanoma is the sixth most common form of cancer in the United States. Moreover, it is the third mos...
We report a series of 240 patients with single brain metastases operated on between 1976 and 1993, T...
Background. Historically, melanoma with brain metastases has a poor prognosis. In this retrospective...
Background: Brain metastases are observed in more than 40% of all patients with stage 4 melanoma. In...
Melanoma spreads to the CNS with an incidence of 4 to 20%. Metastases from cancer of the colorectal ...
Thirty-four breast cancer patients with single brain metastases were reviewed: 9 underwent surgical ...
AIM: Improved systemic treatment has improved the prognosis of metastatic melanoma (MM). However, br...
Background Brain metastases occur in 10%–40% of patients with cancer and are more common than primar...
The management of melanoma brain metastases (MBM) includes different therapeutic modalities, such as...
Brain metastases (BM) are among the most devastating and debilitating complications of melanoma. Thi...
Cerebral metastases are a common cause of death in patients with melanoma. Systemic drug treatment o...
ABSTRACT CONTEXT: Malignant melanoma is the third most common cause of cerebral metastases after br...
Despite review papers claim for radical treatment of oligometastatic patients, only few surgical ser...
With an incidence of 15/10(5) in the general population, brain metastases constitute a serious, debi...
BACKGROUND: Brain metastasis is a common endpoint in patients suffering from malignant melanoma. How...